» Articles » PMID: 11292700

Gender is a Major Factor in Determining the Severity of Mycoplasma Respiratory Disease in Mice

Overview
Journal Infect Immun
Date 2001 Apr 9
PMID 11292700
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Gender is a significant factor in determining the susceptibility to and severity of pulmonary diseases in both humans and animals. Murine respiratory mycoplasmosis (MRM), due to Mycoplasma pulmonis infection, is an excellent animal model for evaluation of the role of various host factors on the development of acute or chronic inflammatory lung diseases. MRM has many similarities to mycoplasma respiratory disease in humans. The purpose of the present study was to determine whether gender has a significant impact on lung disease due to M. pulmonis infection in mice. It was demonstrated that male mice consistently developed more severe disease in the lung parenchyma than did female mice. There was no gender difference in disease severity along the airways or any difference in mycoplasma numbers in lungs of male and female mice. Furthermore, surgical removal of reproductive organs reduced the severity of mycoplasma disease and the numbers of mycoplasma organisms recovered from lungs. Thus, gender plays a significant role in determining the severity of M. pulmonis disease. In fact, the gender of the host was a major factor in determining whether an acute or chronic inflammatory lung disease developed after infection with M. pulmonis.

Citing Articles

Significance of Hemorheological Tests During Mycoplasma Pulmonis Infection in Laboratory Rats.

Deak A, Bedocs-Barath B, Varga A, Matrai A, Bacskai T, Deak-Pocsai K Animals (Basel). 2025; 15(4).

PMID: 40003044 PMC: 11852131. DOI: 10.3390/ani15040563.


Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Infection: A Descriptive Study.

Xing F, Chiu K, Deng C, Ye H, Sun L, Su Y Antibiotics (Basel). 2024; 13(3).

PMID: 38534697 PMC: 10967482. DOI: 10.3390/antibiotics13030262.


The conneXion between sex and immune responses.

Forsyth K, Jiwrajka N, Lovell C, Toothacre N, Anguera M Nat Rev Immunol. 2024; 24(7):487-502.

PMID: 38383754 PMC: 11216897. DOI: 10.1038/s41577-024-00996-9.


Refractory Escherichia Coli Pneumonia: A Case Report.

Khalafi S, De La Rosa Vaquez A, Dihowm F Cureus. 2023; 15(2):e35226.

PMID: 36968935 PMC: 10032549. DOI: 10.7759/cureus.35226.


The Lung Alveolar Cell (LAC) miRNome and Gene Expression Profile of the SP-A-KO Mice After Infection With and Without Rescue With Human Surfactant Protein-A2 (1A).

Thorenoor N, Floros J Front Immunol. 2022; 13:854434.

PMID: 35844510 PMC: 9283764. DOI: 10.3389/fimmu.2022.854434.


References
1.
Angele M, Knoferl M, Schwacha M, Ayala A, Cioffi W, Bland K . Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol. 1999; 277(1):C35-42. DOI: 10.1152/ajpcell.1999.277.1.C35. View

2.
Davis J, Cassell G . Murine respiratory mycoplasmosis in LEW and F344 rats: strain differences in lesion severity. Vet Pathol. 1982; 19(3):280-93. DOI: 10.1177/030098588201900306. View

3.
Cassell G . Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev Infect Dis. 1982; 4 Suppl:S18-34. DOI: 10.1093/clinids/4.supplement_1.s18. View

4.
Lindsey J, Baker H, Overcash R, Cassell G, Hunt C . Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971; 64(3):675-708. PMC: 2047606. View

5.
Loeb M, McGeer A, McArthur M, Walter S, Simor A . Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 1999; 159(17):2058-64. DOI: 10.1001/archinte.159.17.2058. View